 | • レポートコード：MRC2312MG14807 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の酢酸デスモプレシン注射液市場規模と予測を収録しています。・世界の酢酸デスモプレシン注射液市場：売上、2018年-2023年、2024年-2029年 ・世界の酢酸デスモプレシン注射液市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の酢酸デスモプレシン注射液市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「4μg/1ml」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 酢酸デスモプレシン注射液のグローバル主要企業は、Pfizer、 JYMetech、 Hybio Pharmaceutical、 Sintanovo、 UBI Pharma、 FERRING PHARMSなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、酢酸デスモプレシン注射液のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の酢酸デスモプレシン注射液市場：タイプ別、2018年-2023年、2024年-2029年 世界の酢酸デスモプレシン注射液市場：タイプ別市場シェア、2022年 ・4μg/1ml、15μg/1ml 世界の酢酸デスモプレシン注射液市場：用途別、2018年-2023年、2024年-2029年 世界の酢酸デスモプレシン注射液市場：用途別市場シェア、2022年 ・糖尿病、血友病A、フォンウィルブランド病、その他 世界の酢酸デスモプレシン注射液市場：地域・国別、2018年-2023年、2024年-2029年 世界の酢酸デスモプレシン注射液市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における酢酸デスモプレシン注射液のグローバル売上、2018年-2023年 ・主要企業における酢酸デスモプレシン注射液のグローバル売上シェア、2022年 ・主要企業における酢酸デスモプレシン注射液のグローバル販売量、2018年-2023年 ・主要企業における酢酸デスモプレシン注射液のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer、 JYMetech、 Hybio Pharmaceutical、 Sintanovo、 UBI Pharma、 FERRING PHARMS ************************************************************* ・調査・分析レポートの概要 酢酸デスモプレシン注射液市場の定義 市場セグメント 世界の酢酸デスモプレシン注射液市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の酢酸デスモプレシン注射液市場規模 世界の酢酸デスモプレシン注射液市場規模：2022年 VS 2029年 世界の酢酸デスモプレシン注射液市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの酢酸デスモプレシン注射液の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の酢酸デスモプレシン注射液製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：4μg/1ml、15μg/1ml 酢酸デスモプレシン注射液のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：糖尿病、血友病A、フォンウィルブランド病、その他 酢酸デスモプレシン注射液の用途別グローバル売上・予測 ・地域別市場分析 地域別酢酸デスモプレシン注射液市場規模 2022年と2029年 地域別酢酸デスモプレシン注射液売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer、 JYMetech、 Hybio Pharmaceutical、 Sintanovo、 UBI Pharma、 FERRING PHARMS ... |
This research report provides a comprehensive analysis of the Desmopressin Acetate Injection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Desmopressin Acetate Injection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Desmopressin Acetate Injection, challenges faced by the industry, and potential opportunities for market players.
The global Desmopressin Acetate Injection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Desmopressin Acetate Injection market presents opportunities for various stakeholders, including Diabetes Insipidus, Hemophilia A. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Desmopressin Acetate Injection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Desmopressin Acetate Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Desmopressin Acetate Injection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Desmopressin Acetate Injection market.
Market Overview: The report provides a comprehensive overview of the Desmopressin Acetate Injection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 4 mcg/1 ml, 15 mcg/1 ml), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Desmopressin Acetate Injection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Desmopressin Acetate Injection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Desmopressin Acetate Injection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Desmopressin Acetate Injection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Desmopressin Acetate Injection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Desmopressin Acetate Injection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Desmopressin Acetate Injection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Desmopressin Acetate Injection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Desmopressin Acetate Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
4 mcg/1 ml
15 mcg/1 ml
Market segment by Application
Diabetes Insipidus
Hemophilia A
Von Willebrand Disease
Other
Global Desmopressin Acetate Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer
JYMetech
Hybio Pharmaceutical
Sintanovo
UBI Pharma
FERRING PHARMS
Outline of Major Chapters:
Chapter 1: Introduces the definition of Desmopressin Acetate Injection, market overview.
Chapter 2: Global Desmopressin Acetate Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Desmopressin Acetate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Desmopressin Acetate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Desmopressin Acetate Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Desmopressin Acetate Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Desmopressin Acetate Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Desmopressin Acetate Injection Overall Market Size
2.1 Global Desmopressin Acetate Injection Market Size: 2022 VS 2029
2.2 Global Desmopressin Acetate Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Desmopressin Acetate Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Desmopressin Acetate Injection Players in Global Market
3.2 Top Global Desmopressin Acetate Injection Companies Ranked by Revenue
3.3 Global Desmopressin Acetate Injection Revenue by Companies
3.4 Global Desmopressin Acetate Injection Sales by Companies
3.5 Global Desmopressin Acetate Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Desmopressin Acetate Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Desmopressin Acetate Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Desmopressin Acetate Injection Players in Global Market
3.8.1 List of Global Tier 1 Desmopressin Acetate Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Desmopressin Acetate Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Desmopressin Acetate Injection Market Size Markets, 2022 & 2029
4.1.2 4 mcg/1 ml
4.1.3 15 mcg/1 ml
4.2 By Type – Global Desmopressin Acetate Injection Revenue & Forecasts
4.2.1 By Type – Global Desmopressin Acetate Injection Revenue, 2018-2023
4.2.2 By Type – Global Desmopressin Acetate Injection Revenue, 2024-2029
4.2.3 By Type – Global Desmopressin Acetate Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Desmopressin Acetate Injection Sales & Forecasts
4.3.1 By Type – Global Desmopressin Acetate Injection Sales, 2018-2023
4.3.2 By Type – Global Desmopressin Acetate Injection Sales, 2024-2029
4.3.3 By Type – Global Desmopressin Acetate Injection Sales Market Share, 2018-2029
4.4 By Type – Global Desmopressin Acetate Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Desmopressin Acetate Injection Market Size, 2022 & 2029
5.1.2 Diabetes Insipidus
5.1.3 Hemophilia A
5.1.4 Von Willebrand Disease
5.1.5 Other
5.2 By Application – Global Desmopressin Acetate Injection Revenue & Forecasts
5.2.1 By Application – Global Desmopressin Acetate Injection Revenue, 2018-2023
5.2.2 By Application – Global Desmopressin Acetate Injection Revenue, 2024-2029
5.2.3 By Application – Global Desmopressin Acetate Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Desmopressin Acetate Injection Sales & Forecasts
5.3.1 By Application – Global Desmopressin Acetate Injection Sales, 2018-2023
5.3.2 By Application – Global Desmopressin Acetate Injection Sales, 2024-2029
5.3.3 By Application – Global Desmopressin Acetate Injection Sales Market Share, 2018-2029
5.4 By Application – Global Desmopressin Acetate Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Desmopressin Acetate Injection Market Size, 2022 & 2029
6.2 By Region – Global Desmopressin Acetate Injection Revenue & Forecasts
6.2.1 By Region – Global Desmopressin Acetate Injection Revenue, 2018-2023
6.2.2 By Region – Global Desmopressin Acetate Injection Revenue, 2024-2029
6.2.3 By Region – Global Desmopressin Acetate Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Desmopressin Acetate Injection Sales & Forecasts
6.3.1 By Region – Global Desmopressin Acetate Injection Sales, 2018-2023
6.3.2 By Region – Global Desmopressin Acetate Injection Sales, 2024-2029
6.3.3 By Region – Global Desmopressin Acetate Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Desmopressin Acetate Injection Revenue, 2018-2029
6.4.2 By Country – North America Desmopressin Acetate Injection Sales, 2018-2029
6.4.3 US Desmopressin Acetate Injection Market Size, 2018-2029
6.4.4 Canada Desmopressin Acetate Injection Market Size, 2018-2029
6.4.5 Mexico Desmopressin Acetate Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Desmopressin Acetate Injection Revenue, 2018-2029
6.5.2 By Country – Europe Desmopressin Acetate Injection Sales, 2018-2029
6.5.3 Germany Desmopressin Acetate Injection Market Size, 2018-2029
6.5.4 France Desmopressin Acetate Injection Market Size, 2018-2029
6.5.5 U.K. Desmopressin Acetate Injection Market Size, 2018-2029
6.5.6 Italy Desmopressin Acetate Injection Market Size, 2018-2029
6.5.7 Russia Desmopressin Acetate Injection Market Size, 2018-2029
6.5.8 Nordic Countries Desmopressin Acetate Injection Market Size, 2018-2029
6.5.9 Benelux Desmopressin Acetate Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Desmopressin Acetate Injection Revenue, 2018-2029
6.6.2 By Region – Asia Desmopressin Acetate Injection Sales, 2018-2029
6.6.3 China Desmopressin Acetate Injection Market Size, 2018-2029
6.6.4 Japan Desmopressin Acetate Injection Market Size, 2018-2029
6.6.5 South Korea Desmopressin Acetate Injection Market Size, 2018-2029
6.6.6 Southeast Asia Desmopressin Acetate Injection Market Size, 2018-2029
6.6.7 India Desmopressin Acetate Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Desmopressin Acetate Injection Revenue, 2018-2029
6.7.2 By Country – South America Desmopressin Acetate Injection Sales, 2018-2029
6.7.3 Brazil Desmopressin Acetate Injection Market Size, 2018-2029
6.7.4 Argentina Desmopressin Acetate Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Desmopressin Acetate Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Desmopressin Acetate Injection Sales, 2018-2029
6.8.3 Turkey Desmopressin Acetate Injection Market Size, 2018-2029
6.8.4 Israel Desmopressin Acetate Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Desmopressin Acetate Injection Market Size, 2018-2029
6.8.6 UAE Desmopressin Acetate Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Desmopressin Acetate Injection Major Product Offerings
7.1.4 Pfizer Desmopressin Acetate Injection Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 JYMetech
7.2.1 JYMetech Company Summary
7.2.2 JYMetech Business Overview
7.2.3 JYMetech Desmopressin Acetate Injection Major Product Offerings
7.2.4 JYMetech Desmopressin Acetate Injection Sales and Revenue in Global (2018-2023)
7.2.5 JYMetech Key News & Latest Developments
7.3 Hybio Pharmaceutical
7.3.1 Hybio Pharmaceutical Company Summary
7.3.2 Hybio Pharmaceutical Business Overview
7.3.3 Hybio Pharmaceutical Desmopressin Acetate Injection Major Product Offerings
7.3.4 Hybio Pharmaceutical Desmopressin Acetate Injection Sales and Revenue in Global (2018-2023)
7.3.5 Hybio Pharmaceutical Key News & Latest Developments
7.4 Sintanovo
7.4.1 Sintanovo Company Summary
7.4.2 Sintanovo Business Overview
7.4.3 Sintanovo Desmopressin Acetate Injection Major Product Offerings
7.4.4 Sintanovo Desmopressin Acetate Injection Sales and Revenue in Global (2018-2023)
7.4.5 Sintanovo Key News & Latest Developments
7.5 UBI Pharma
7.5.1 UBI Pharma Company Summary
7.5.2 UBI Pharma Business Overview
7.5.3 UBI Pharma Desmopressin Acetate Injection Major Product Offerings
7.5.4 UBI Pharma Desmopressin Acetate Injection Sales and Revenue in Global (2018-2023)
7.5.5 UBI Pharma Key News & Latest Developments
7.6 FERRING PHARMS
7.6.1 FERRING PHARMS Company Summary
7.6.2 FERRING PHARMS Business Overview
7.6.3 FERRING PHARMS Desmopressin Acetate Injection Major Product Offerings
7.6.4 FERRING PHARMS Desmopressin Acetate Injection Sales and Revenue in Global (2018-2023)
7.6.5 FERRING PHARMS Key News & Latest Developments
8 Global Desmopressin Acetate Injection Production Capacity, Analysis
8.1 Global Desmopressin Acetate Injection Production Capacity, 2018-2029
8.2 Desmopressin Acetate Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Desmopressin Acetate Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Desmopressin Acetate Injection Supply Chain Analysis
10.1 Desmopressin Acetate Injection Industry Value Chain
10.2 Desmopressin Acetate Injection Upstream Market
10.3 Desmopressin Acetate Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Desmopressin Acetate Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer